MENU
+Compare
NKTR
Stock ticker: NASDAQ
AS OF
Feb 21 closing price
Price
$0.93
Change
-$0.03 (-3.12%)
Capitalization
171.95M

NKTR Nektar Therapeutics Forecast, Technical & Fundamental Analysis

a developer of inhalation drug delivery systems

Industry Biotechnology
NKTR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I.Advisor
a Summary for NKTR with price predictions
Feb 21, 2025

Momentum Indicator for NKTR turns positive, indicating new upward trend

NKTR saw its Momentum Indicator move above the 0 level on February 13, 2025. This is an indication that the stock could be shifting in to a new upward move. Traders may want to consider buying the stock or buying call options. Tickeron's A.I.dvisor looked at 81 similar instances where the indicator turned positive. In of the 81 cases, the stock moved higher in the following days. The odds of a move higher are at .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Moving Average Convergence Divergence (MACD) for NKTR just turned positive on February 13, 2025. Looking at past instances where NKTR's MACD turned positive, the stock continued to rise in of 47 cases over the following month. The odds of a continued upward trend are .

NKTR moved above its 50-day moving average on February 14, 2025 date and that indicates a change from a downward trend to an upward trend.

Following a +1 3-day Advance, the price is estimated to grow further. Considering data from situations where NKTR advanced for three days, in of 236 cases, the price rose further within the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

The 10-day RSI Indicator for NKTR moved out of overbought territory on February 19, 2025. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 20 similar instances where the indicator moved out of overbought territory. In of the 20 cases, the stock moved lower in the following days. This puts the odds of a move lower at .

The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 3 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where NKTR declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

NKTR broke above its upper Bollinger Band on February 14, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

The Aroon Indicator for NKTR entered a downward trend on February 18, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. NKTR’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (3.517) is normal, around the industry mean (12.496). P/E Ratio (0.000) is within average values for comparable stocks, (84.451). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.603). NKTR has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.012). P/S Ratio (2.012) is also within normal values, averaging (251.218).

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to slightly better than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. NKTR’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.

View a ticker or compare two or three
NKTR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published Earnings

NKTR is expected to report earnings to fall 11.17% to -15 cents per share on February 27

Nektar Therapeutics NKTR Stock Earnings Reports
Q4'24
Est.
$-0.16
Q3'24
Beat
by $0.02
Q2'24
Missed
by $0.06
Q1'24
Missed
by $0.04
Q4'23
Missed
by $0.02
The last earnings report on November 07 showed earnings per share of -18 cents, beating the estimate of -20 cents. With 1.22M shares outstanding, the current market capitalization sits at 171.95M.
A.I. Advisor
published General Information

General Information

a developer of inhalation drug delivery systems

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
455 Mission Bay Boulevard South
Phone
+1 415 482-5300
Employees
137
Web
https://www.nektar.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
EMRGX7.100.03
+0.42%
Emerging Markets Growth Fund M
FVALX5.050.02
+0.40%
Forester Value N
MDMIX26.42-0.15
-0.56%
Madison Dividend Income I
FGRAX49.05-1.34
-2.66%
Franklin Growth Opportunities A
EKWCX58.42-1.61
-2.68%
Allspring Precious Metals C

NKTR and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, NKTR has been loosely correlated with SLS. These tickers have moved in lockstep 42% of the time. This A.I.-generated data suggests there is some statistical probability that if NKTR jumps, then SLS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NKTR
1D Price
Change %
NKTR100%
-2.58%
SLS - NKTR
42%
Loosely correlated
-3.05%
NTLA - NKTR
41%
Loosely correlated
-0.65%
DNLI - NKTR
39%
Loosely correlated
-3.98%
MDGL - NKTR
38%
Loosely correlated
-4.22%
IPSC - NKTR
37%
Loosely correlated
-2.51%
More